Allspring Global Investments
BIO icon

Allspring Global Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Allspring Global Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7M Sell
69,598
-16,367
-19% -$4.64M 0.03% 547
2026
Q1 		$23.9M Sell
85,965
-43,246
-33% -$12.5M 0.04% 489
2025
Q4 		$39.4M Sell
129,211
-5,556
-4% -$1.73M 0.06% 355
2025
Q3 		$40.2M Buy
134,767
+4,262
+3% +$1.16M 0.06% 354
2025
Q2 		$32.4M Sell
130,505
-5,442
-4% -$1.29M 0.05% 393
2025
Q1 		$32.6M Sell
135,947
-7,790
-5% -$2.34M 0.06% 388
2024
Q4 		$46.9M Sell
143,737
-4,985
-3% -$1.69M 0.08% 312
2024
Q3 		$49.8M Sell
148,722
-7,691
-5% -$2.44M 0.08% 316
2024
Q2 		$42.7M Sell
156,413
-7,370
-4% -$2.14M 0.07% 343
2024
Q1 		$56.6M Sell
163,783
-2,344
-1% -$771K 0.09% 285
2023
Q4 		$53.6M Buy
166,127
+17,341
+12% +$5.44M 0.09% 299
2023
Q3 		$53.3M Sell
148,786
-86,117
-37% -$33.2M 0.09% 275
2023
Q2 		$89.1M Sell
234,903
-24,299
-9% -$9.89M 0.14% 172
2023
Q1 		$124M Sell
259,202
-12,785
-5% -$5.98M 0.21% 113
2022
Q4 		$114M Buy
271,987
+5,282
+2% +$2.13M 0.2% 127
2022
Q3 		$111M Buy
266,705
+34,780
+15% +$17.3M 0.2% 124
2022
Q2 		$115M Sell
231,925
-51,665
-18% -$26.9M 0.19% 130
2022
Q1 		$160M Buy
283,590
+26,539
+10% +$16M 0.2% 123
2021
Q4 		$194M Buy
+257,051
New +$192M 0.22% 115

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Allspring Global Investments's BIO Position: Q2 2026 in Review

Allspring Global Investments reduced its Bio-Rad Laboratories Class A (BIO) stake by 19% in Q2 2026, selling an estimated $4.64M and leaving 69,598 shares worth $20.7M. The position accounts for 0.03% of the portfolio, ranked #547.

Allspring Global Investments first reported a position in BIO in Q4 2021 and has held it in 19 quarters since. The position peaked at $194M in Q4 2021. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Allspring Global Investments held 69,598 shares of Bio-Rad Laboratories Class A worth $20.7M as of Q2 2026.
  • Allspring Global Investments sold 16,367 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $4.64M.
  • Bio-Rad Laboratories Class A made up 0.03% of Allspring Global Investments's portfolio in Q2 2026, its #547 holding.
  • Allspring Global Investments first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Bio-Rad Laboratories Class A position peaked at $194M in Q4 2021.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.